Cite
HARVARD Citation
Wasiak, S. et al. (n.d.). BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients. Molecular immunology. pp. 127-128. [Online].